Tokyo Big Sight

Oct 19, 2025 9:30 AM - Oct 21, 2025 6:00 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

The 22nd DIA Japan Annual Meeting 2025

Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients

Overview

Click Here to View the Flyer


22nd DIA Japan Annual Meeting 2025 will be held at Tokyo Big-Sight from October 19 to October 21, 2025.

The theme of this meeting is "Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients." With the globalization of medical care, including recent progress in the use of AI/digital technology for building more efficient ecosystems and processes worldwide, the environment surrounding the development and pharmacovigilance of drugs and other medical products is rapidly changing. In these circumstances, the Asian region plays a major role in the advancement of healthcare systems around the world, and further collaboration among Japan, Asia, and the world will promote medical innovation and provide innovative medical products to patients.


This year's meeting offers an opportunity for all local and global stakeholders who are considering the future of medical care to strengthen their partnerships, including cross-border cooperation, to promote innovation and advance medical care by sharing their knowledge and experiences. At this meeting, we will collaborate together to create “Tomorrow’s Normal” in which everyone can feel peaceful and lead vibrant and healthy lives.

This year’s meeting has also established an English-language track to enable more globally interactive sessions with local and overseas experts, generate active discussions on ways to further advance medical innovation through sharing the latest knowledge on the current medical product development and post-marketing environments, and strengthen cooperation among Japan, Asia, and the world.


We invite you to share your knowledge and experience at the 22nd DIA Japan Annual Meeting 2025 so that we can think together about “Delivering ‘Tomorrow’s Normal’ to Patients,” and sincerely look forward to your active participation.

 

Program Committee

  • Yasuhiro  Fujiwara, MD, PhD
    Yasuhiro Fujiwara, MD, PhD Chief Executive
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Keiko  Tsumori, MSc
    Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Yoshiaki  Uyama, PhD, MS, RPh
    Yoshiaki Uyama, PhD, MS, RPh Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Asami  Ezaki, MS
    Asami Ezaki, MS Division Director, PR Section, Office of Planning and Operations
    Pharmaceuticals and Medeical Devices Agency (PMDA), Japan
  • Hiroya  Nakamura
    Hiroya Nakamura Employee
    Pharmaceuticals and Medical Devices Agency, Japan
  • Yuko  Hata
    Yuko Hata Associate director, Therapeutic Area Regulatory, Japan Regulatory Affairs
    Takeda Pharmaceutical Company, Japan
  • Masaaki  Jitsu
    Masaaki Jitsu
    Bayer Yakuhin Ltd, Japan
  • Yuki  Kai, MBA
    Yuki Kai, MBA Clinical Strategy and Resource Management Department, Clinical Development Divis
    Chugai Pharmaceutical Co., Ltd.,, Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.